[vc_row][vc_column][vc_column_text]The GASCDO is grateful to Novartis and Pfizer for the generous financial contributions made to support GASCDO’s inaugural meetings. It is also building relationship with many other pharmaceuticals with interest in sickle cell disease.
If your pharmaceutical or corporation will like to learn more about GASCDO and support its vision of advancing SCD globally, please reach out to our corporate relations function at: cr@scdglobal.org.
Corporate Partners
Novartis
Pfizer
Sanofi Genzyme
Bluebird bio
Global Blood Therapeutics[/vc_column_text][/vc_column][/vc_row]